APA (7th ed.) Citation

EAR, G., R, P., RC, G., AJ, L., KF, R., OH, B., . . . TM, J. (2026). Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: A phase 1 trial. Nature cancer, 7(7), 1064. https://doi.org/10.1038/s43018-026-01163-w

Chicago Style (17th ed.) Citation

EAR, Garfinkle, et al. "Adjuvant Personalized Multivalent Neoantigen DNA Vaccination for MGMT Unmethylated Glioblastoma: A Phase 1 Trial." Nature Cancer 7, no. 7 (2026): 1064. https://doi.org/10.1038/s43018-026-01163-w.

MLA (9th ed.) Citation

EAR, Garfinkle, et al. "Adjuvant Personalized Multivalent Neoantigen DNA Vaccination for MGMT Unmethylated Glioblastoma: A Phase 1 Trial." Nature Cancer, vol. 7, no. 7, 2026, p. 1064, https://doi.org/10.1038/s43018-026-01163-w.